Technology Platform

At ImmuNova BioMed, we are redefining healthcare through cutting-edge research and advanced biotechnological solutions. Our product portfolio currently includes:

A close-up view of various pills and capsules in blister packs, including brown capsules and white round tablets. The blister packs are arranged haphazardly, with some lying flat and others overlapping. The lighting highlights the shiny surface of the packaging, creating reflections.
A close-up view of various pills and capsules in blister packs, including brown capsules and white round tablets. The blister packs are arranged haphazardly, with some lying flat and others overlapping. The lighting highlights the shiny surface of the packaging, creating reflections.
Nanoparticles for Precision Drug Delivery

ImmuNova BioMed’s proprietary nanoparticle delivery system optimizes the targeting and uptake of antigens, immune modulators, or drugs by the immune system. These biodegradable nanoparticles are designed for controlled release, maximizing therapeutic efficacy while minimizing side effects.

A collection of various pills and capsules, including a prominent green gel capsule and a heart-shaped white tablet. The image has a colorful and slightly abstract presentation with a blurred, artistic style.
A collection of various pills and capsules, including a prominent green gel capsule and a heart-shaped white tablet. The image has a colorful and slightly abstract presentation with a blurred, artistic style.
Self-Assembling Nanovaccines

Our core technology employs self-assembling nanovaccines customizable for various diseases. These nanovaccines efficiently deliver antigens to immune cells, eliciting stronger and longer-lasting immune responses.

Intricate structures resembling nanofibers or cellular formations are depicted with a blend of purple and gold hues. The surfaces are perforated with numerous small holes, creating an intricate, organic appearance. The background is a smooth gradient of dark purples, enhancing the vibrant colors of the main elements.
Intricate structures resembling nanofibers or cellular formations are depicted with a blend of purple and gold hues. The surfaces are perforated with numerous small holes, creating an intricate, organic appearance. The background is a smooth gradient of dark purples, enhancing the vibrant colors of the main elements.
AI-Driven Personalization

Using advanced machine learning algorithms, we develop personalized treatment strategies based on patient-specific immune profiles and tumor characteristics. This ensures highly individualized therapies tailored to each patient’s unique disease progression.

Research and development

ImmuNova BioMed is deeply invested in R&D, collaborating with leading academic institutions and medical research centers. Key initiatives include:

Next-Generation Cancer Vaccines: Targeting neoantigens for enhanced immune response. Post-Surgical Cancer Immunotherapies: Reducing recurrence rates with novel approaches. Combination Therapies: Integrating nanovaccines with standard chemotherapy or radiation for superior outcomes.

ImmuNovaBioMed B.V.

Pioneering peptide-based solutions for global health.

Expertise

Vision

contact@immunovabiomed.com

+31-

© 2025. All rights reserved.